- Release Date: 03/06/21 08:49
- Summary: Upgraded FY21 earnings guidance by 10 to 15%
- Price Sensitive: Yes
- Download Document 358.88KB
- Forums
- ASX - By Stock
- ACL
- Ann: Upgraded FY21 earnings guidance by 10 to 15%
ACL
australian clinical labs limited
Add to My Watchlist
3.44%
!
$2.53

Ann: Upgraded FY21 earnings guidance by 10 to 15%
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.53 |
Change
-0.090(3.44%) |
Mkt cap ! $498.8M |
Open | High | Low | Value | Volume |
$2.61 | $2.63 | $2.53 | $928.8K | 361.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 6853 | $2.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.54 | 12906 | 34 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 8384 | 2.530 |
20 | 31328 | 2.520 |
15 | 43340 | 2.510 |
23 | 131863 | 2.500 |
10 | 24159 | 2.490 |
Price($) | Vol. | No. |
---|---|---|
2.540 | 12018 | 35 |
2.550 | 11469 | 34 |
2.560 | 33493 | 20 |
2.570 | 14696 | 15 |
2.580 | 32256 | 9 |
Last trade - 13.20pm 09/09/2025 (20 minute delay) ? |
Featured News
ACL (ASX) Chart |